In our work, transcriptomic studies revealed that functions involved in DNA damage such as those classified as ATM, ATR, Fanconi Anemia, and BARD1 pathways are clearly dysregulated in breast tumors, particularly in the basal-like and HER2 subtype. This evidence concerns the gene ERBB2 and breast neoplasm.